\
&
Contact us
\
&
Contact us
Starts in 3 months from now
LocationBrussels
The Commission’s Advanced Digital Skills and Women in Digital flagships will join forces for a combined stakeholder event, providing a key moment to accelerate progress towards the Digital Decade target of 20 million ICT specialists and greater gender balance in tech.
This cooperation reflects the EU’s ambition set out in the Union of Skills and AI Continent Action Plan: to boost Europe’s global leadership and competitiveness through highly skilled talent and strengthen its capacity to lead in advanced digital technologies.
The Summits invite the most relevant stakeholders and leaders from industry, education, training and policy to share the latest state-of-play, data, best practice and promote joint actions to unlock the talent pipeline and lay the foundations of the future advanced digital skills academies.
Registrations are expected to open soon. For more information on the event and the applications for the European Digital Skills Awards (deadline 15 July), please visit the event website.
We offer news and event updates, covering all domains and topics of Horizon Europe, Digital Europe & EDF (and occasionally, for ongoing projects, Horizon 2020).
Stay informed about what matters to you.
By signing up, you can opt in for e-mail notifications and get access to
a personalised dashboard that groups all news updates and event announcements in your domain(s).
Only for stakeholders located in Flanders
The METHYLOMIC project, ‘targeting hope for personalised medicine in immune-mediated inflammatory diseases’ obtained funding from Horizon Europe’s Health Cluster. The project aims to personalise treatment allocation and enhance the effectiveness of medications for chronic immune-mediated diseases such as Crohn’s disease, rheumatoid arthritis, and psoriasis. BIRD, the Belgian inflammatory bowel disease research and development group, is a partner in the project and is involved in the OmiCrohn trial, a prospective randomised clinical trial for individualised therapy in Crohn’s disease patients. With BIRD’s active role in this trial, the project is set to deliver predictive, biomarker-based therapies that bring renewed hope for Crohn’s disease patients across Europe.
